EP3349740
CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.9.2016EP published:
21.4.2021EP application number:
16771043.3
EPO information:
European Patent Register
Max expiry date:
12.9.2036
Title:
CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
Timeline
Today
13.9.2016EP application
21.4.2021EP Publication
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
ROSENTHAL, Norman R.Address:
Raritan, New Jersey 08869, US
Name:
ROTHENBERG, PaulAddress:
Raritan, New Jersey 08869, US
Name:
POLIDORI, David C.Address:
San Diego, California 92121, US
Name:
WAYS, Douglas K.Address:
Raritan, New Jersey 08869, US
Name:
STEIN, Peter P.Address:
Princeton, New Jersey 08550, US
Priority
Number:
201562218842 PDate:
15.9.2015Country:
US
Number:
201662306110 PDate:
10.3.2016Country:
US
Number:
201615262038Date:
12.9.2016Country:
US
Classification
Categories:
A61K 31/137, A61K 31/7042, A61P 3/04, A61P 3/00, A61P 9/00, A61P 9/12, A61P 13/00, A61P 1/16, A61P 43/00